Table 1.
Disorder | Tissue/samplea | Sample size | Method | TE copy number | TE DNA methylation | TE expression | Reference |
---|---|---|---|---|---|---|---|
Rett syndrome | Neural progenitor cells derived from induced pluripotent stem cells | Rhett syndrome: n = 5 Control: n = 5 | L1 5′UTR-Luciferase plasmid | Increased L1 retrotransposition | Muotri et al. (2010) | ||
Ataxia telangiectasia (Louis-Bar syndrome) | Post-mortem hippocampal tissue | Ataxia telangiectasia: n = 7 Control: n = 7 | Taqman q-PCR | Increased L1 ORF2 copy number | Coufal et al. (2011) | ||
Rett syndrome, Ataxia telangiectasia, tuberous sclerosis complex, nonsyndromic autism | Post-mortem cerebellar, occipital, and frontal cortex tissue | Pathologic: n = 17 Non-pathologic: n = 5 (various areas) | Whole-genome mapping | Increased L1 and Alu retrotransposition | Jacobs-Hirsh et al. (2018) | ||
ASD | Peripheral blood | ASD: n = 28 Control: n = 28 | PCR amplification, gel electrophoresis for presence/absence detection | More individuals with ERV-H and HERV-W expression | Balestrier et al. (2012) | ||
ASD | Post-mortem cerebellum, BA9, BA22, and BA24 | ASD: n = 13 Control: n = 13 | Taqman q-PCR | Higher L1 in cerebellum, no difference in other regions | Shpyleva et al. (2018) | ||
ASD | Existing peripheral blood transcriptome data from NCBI Gene Expression Omnibus DataSets | ASD: n = 465 Control: n = 256 | Ingenuity Pathway Analysis of differentially expressed genes | Increased L1 insertions near genes involved in sex hormone receptor signaling and axon guidance | Tangsuwansri et al. (2018) | ||
ASD | Existing peripheral blood transcriptome data from NCBI Gene Expression Omnibus DataSets | ASD: n = 36 Control: n = 20 | Ingenuity Pathway Analysis of differentially expressed genes | Alu methylation varied by ASD subtype | Saeliw et al. (2018) | ||
ASD with severe language impairment | Lymphoblastoid cell lines | ASD: n = 36 Control: n = 20 | Combined bisulfite restriction analysis, qPCR | L1 hypomethylation | L1 methylation negatively associated with L1 expression | Tangsuwansri et al. (2018) | |
Schizophrenia | Cell-free cerebrospinal fluid, postmortem frontal cortex | Schizophrenia (CFS): n = 55 Control (CFS): n = 12 Schizophrenia (brain): n = 5 Control (brain): n = 6 | Nested PCR & gel electrophoresis visualization, sequencing | More individuals with HERV-W expression in CFS, increased HERV-W expression in frontal cortex | Karlsson et al. (2001) | ||
Schizophrenia & Bipolar disorder | Peripheral blood | Bipolar disorder: n = 110 Schizophrenia: n = 59 control: n = 105 |
Taqman q-PCR, sequencing | Decreased HERV-W copy number | Elevated ERV-W expression | Perron et al. (2012) | |
Schizophrenia | Serum | Schizophrenia: n = 118 Control: n = 106 | Nested PCR & gel electrophoresis visualization, sequencing | More individuals with HERV-W evn expression | Huang et al. (2011) | ||
Schizophrenia | Peripheral blood | Schizophrenia: n = 58 Control: n = 38 | Nested PCR & gel electrophoresis visualization, sequencing | More individuals with ERV9 pol expression | Huang et al. (2006) | ||
Schizophrenia | Postmortem dorsolateral PFC tissue | Schizophrenia: n = 13, n = 35 Control: n = 13, n = 34 | Taqman q-PCR | Increased L1 copy number | Bundo et al. (2014) | ||
PolyI:C maternal immune activation (mice), chronic epidermal growth factor (macaque) models of schizophrenia | PFC | PolyI:C (mice): n = 8 Control (mice): n = 8 EGF (macaques): n = 2 Control (macaques): n = 3 | SYBR green q-PCR | Increased L1 copy number | Bundo et al. (2014) | ||
Schizophrenia | Postmortem dorsolateral PFC tissue | Schizophrenia: n = 36 Controls: n = 26 | L1-seq | Increased L1 insertions near genes involved in cell projection and post-synaptic membrane | Doyle et al. (2017) | ||
Schizophrenia with childhood trauma | Peripheral blood leukocytes | Schizophrenia w/trauma: n = 18 Schizophrenia w/o trauma: n = 18 Control: n = 46 | Combined bisulfite restriction analysis, PCR, gel electrophoresis visualization | L1 hypomethylation | Misiak et al. (2015) | ||
Schizophrenia | Peripheral blood, Han Chinese cohort | Schizophrenia: n = 92 Control: n = 92 | Bisulfite conversion-specific one-label extension | L1 hypomethylation | Li et al. (2018) | ||
PTSD | Serum, military service members | PTSD: n = 75 Control: n = 75 | Pyrosequencing | L1 hypomethylation post-deployment, Alu hypermethylation pre-deployment | Rusiecki et al. (2012) | ||
Stress-enhanced fear learning model of PTSD | Rat basolateral amygdala | n = 7–8 | Transcriptomic network analysis | Higher expression of elements containing L1 domains | Ponomarev et al. (2010) | ||
Bipolar disorder | Peripheral blood, Han Chinese cohort | Bipolar: n = 99 Control: n = 92 | Bisulfite conversion-specific one-label extension | L1 hypomethylation | Li et al. (2018) | ||
Major depressive disorder | Postmortem dorsolateral PFC tissue | MDD: n = 12 Control: n = 13 | Taqman q-PCR | Non-significant increase in L1 copy number | Bundo et al. (2014) | ||
Major depressive disorder | Peripheral blood | MDD: n = 105 Control: 105 | Taqman q-PCR, methylation sensitive restriction enzymes | L1 hypomethylation | Higher L1 expression | Liu et al. (2016) | |
Chronic unpredictable mild stress model of depression | Peripheral blood, PFC, hippocampus, nucleus accumbans, paraventricular nucleus of hypothalamus of mice | Depression model: n = 22 Control: n = 12 | SYBR green q-PCR | L1 copy number increased in blood, reduced in PFC, unaffected in other areas | Liu et al. (2016) | ||
Major depressive disorder | Peripheral blood | MDD: n = 122 Control: n = 176 | Bisulfite conversion, PCR amplification, sequencing | AluJb element in serotonin transporter promoter hypomethylation | Schneider et al. (2018) |
All tissues are human unless otherwise specified.